Chargement en cours...
Bone loss and the aromatase inhibitors
The increasing use of systemic adjuvant therapies has considerably improved the prognosis from early breast cancer. However, some of these therapies affect bone metabolism, resulting in osteoporosis. Aromatase inhibitors lower circulating oestrogen levels to almost unrecordable levels in postmenopau...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Nature Publishing Group
2005
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2361688/ https://ncbi.nlm.nih.gov/pubmed/16100521 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602691 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|